USA: US drug giant to spin-off Monsanto agriculture business, cites falling sales
US drugs giant Pharmacia Corp. has revealed its intention to sell its remaining 85% stake in agricultural giant Monsanto during the second half of 2002, to allow it to focus on its core pharmaceuticals business. CEO Fred Hassan announced the planned spin-off during a meeting with analysts and investors in New York yesterday. The deal will involve a tax-free dividend for the shareholders that control the remaining 15% of the business since its was floated in an IPO (initial public offering) during the fourth quarter of 2000.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 16 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Nestle India grows with global, digital innovation
- How Nestle tackles Indian challenges - interview
- Lamb Weston goes it alone: six things to learn
- Analysis: Tyson's shrewd investment in Beyond Meat
- Thailand: convenience to continue to thrive
- Mars launches Maltesers in the US
- Bel takes majority stake in MOM Group
- Campbell backs US nutrition start-up Habit
- Mondelez focuses on margins as sales slip
- Nestle's Buitoni to remove GMOs
- The Big 15: Strategies and Priorities of Top Packaged Food Players in Comparison
- Packaged Food: Quarterly Statement Q3 2016
- Omega-3 in Food and Beverage:Time for a Reboot?
- Global Food Packaging: Innovating for Greater Convenience and Quality Image
- Meat Processing in China - Industry Market Research Report